Home

Deck

Synchrony Financial · SYF · NYSE

Synchrony is the largest U.S. issuer of store-branded and co-branded credit cards, earning the spread between high card interest and cheap deposit funding on loans made through retail partners like Lowe's, Amazon and Sam's Club.

$75
Share price
~$28B
Market cap
$103.8B
Card loans
70.7M
Active accounts
Spun out of GE in a 2014 IPO at $23, Synchrony sank to a $13 low in the March 2020 crash, then ran to an $88 high in January 2026 before easing to ~$75 — nearly 6x off the bottom.
2 · The central tension

An American-Express-grade return, priced like a broken bank — and one variable decides whether that's a bargain.

  • 21% ROE at 8x earnings. Synchrony earns a 21.1% return on equity and 3.0% on assets — returns that rival American Express — yet trades at roughly 8x earnings and 1.7x book, the multiple the market reserves for low-return or troubled lenders.
  • Credit is the swing factor. The whole gap rests on one number: the net charge-off rate. It fell to 5.65% in 2025 from a 6.31% peak, and management guides below 5.5% for 2026 — but that is an improving trend, not a tested full cycle.
  • Two ways to read the same filing. Bulls see a durable run-rate the market is mispricing; bears see earnings flattered by a reserve release booked as loss coverage hit a multi-year low. Both cite the same 10-K.
The two sides agree on every fact. The disagreement is whether the 2025 credit improvement is structural or borrowed.
3 · The money picture

A spread lender with elite returns and a fortress, deposit-funded balance sheet.

$3.55B
Net earnings FY2025 EPS $9.28
15.24%
Net interest margin stable ~15% for a decade
84%
Funded by deposits $81B, mostly retail
12.6%
Core capital ratio fortress, ~$13B cushion

Synchrony's profit is a spread: $22.6B of interest income on $104B of card loans, less funding cost, a contractual profit-share paid back to retail partners, and the provision for credit losses — what survives nets to $3.55B. Deposits now fund 84% of the book, so funding cost falls as rates drop, and the capital the business throws off far exceeds what it needs to grow.

4 · The compounding engine

The share count is melting — which builds per-share value, and masks a profit pool that hasn't grown.

  • 55% fewer shares since 2016. The diluted count has fallen from 831M to 374M; in 2025 Synchrony returned ~$3.3B — about 12% of its market cap — and entered 2026 with a new $6.5B buyback authorization worth roughly a fifth of the company.
  • Mechanically accretive. Repurchasing a 21% ROE business below 1.7x book lifts book value and earnings per remaining share whether or not the multiple ever re-rates — the per-share case works without the market ever agreeing.
  • But the dollar profit is flat. FY2025 net earnings of $3.55B sit below the $3.75B earned in 2019; all the per-share growth is share-count shrinkage. If credit ever forces capital to be retained, the engine stalls.
This is a return-of-capital compounder, not a growth stock — its strength and its single biggest vulnerability are the same fact.
5 · Earnings quality

The accounting is clean, but recent growth leaned on a reserve release at a delicate moment.

  • Where the growth came from. FY2024's profit jump was mostly a one-time gain on selling the Pets Best unit; FY2025's came from a $1.5B drop in the credit-loss provision — a reserve release — not from revenue, which was essentially flat.
  • Coverage at a multi-year low, in a model-change year. Loss-reserve coverage fell to 10.06%, its lowest since 2020, in the same year management swapped its loss-forecasting model. The auditor named the allowance its sole critical audit matter, citing 'significant measurement uncertainty.'
  • But the foundation is sound. The audit is clean, internal controls are effective, cash flow is honestly presented, and the actual credit data improved — delinquencies and charge-offs both fell, which genuinely supports some reserve relief. The forensic read is 'watch,' not 'avoid.'
The release is defensible while losses keep falling. It turns into a problem only if charge-offs re-accelerate while the thinned reserve holds.
6 · The balance of evidence

Cheap on quality, fairly priced on risk — the case turns on credit and concentration.

  • What supports it. A ~21% ROE franchise returning ~95% of earnings below 1.7x book; charge-offs falling and guided below 5.5% for 2026; the late-fee regulatory threat vacated in April 2025; top partners re-signed out to 2030–2035, with Walmart won back.
  • What cuts against it. Profit hasn't grown in six years; reserve coverage sits at a multi-year low; five programs drive 54% of interest and fees; and a proposed 10% federal APR cap — though a long shot — is the one event that could permanently reprice the model.
  • The synthesis. A 21% ROE machine compounding per-share value is fighting a bear whose core variable is improving — but the cushion is thin, so this reads as 'confirm, then commit,' not a layup.

Watchlist to re-rate: The net charge-off trajectory off the Q2 2026 seasonal peak (July 21) and whether reserve coverage holds without a fresh build; partner renewals and profit-share terms at each major contract; and any real legislative momentum on a 10% APR cap.